Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator
Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator
复制标题
Interleukin-27 通过诱导主要组织相容性复合物 II 类反式激活因子上调原代人内皮细胞中主要组织相容性复合物 II 类的表达
DOI:
10.1016/j.humimm.2007.10.004
复制
发表时间:
2007-12-01
期刊:
影响因子:
2.7
通讯作者:
Han, Zhong Chao
中科院分区:
文献类型:
--
作者:
Feng, Xiao Ming;Chen, Xiao Li;Han, Zhong Chao
Interleukin-27 (IL-27) is a novel IL-12 family member that plays a critical role in the regulation of T-cell responses. Its immunoregulatory effects on endothelial cells (EC) remain unexplored. Here we show a role for IL-27 in the induction of major histocompatibility complex (MHC) expression in primary human EC. Stimulation of human umbilical vein ECs by IL-27 rapidly induces IFN regulatory factor-1 and dramatically increases the expression of major histocompatibility class II transactivator (CIITA) isoform IV. Expression of this transactivator correlates with increased MHC class II gene expression. IL-27 also enhances expression of MHC class I molecules. Furthermore expression of beta 2-microglobulin and transporter associated with antigen processing-1 transcripts increases in response to IL-27. Additional microarray analysis demonstrates that IL-27 significantly upregulates a panel of genes that correlates with immune regulation, including the chemokines CXCL9, CXCL10, and CX3CL1 in human umbilical vein ECs. This first demonstration that both MHC II and I expression are increased in EC after IL-27 stimulation suggests that IL-27 may be important in conferring immune function on vascular endothelium. (C) 2007 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.